Recent advances in statins and the kidney
- 1 July 1999
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 56, S2-S5
- https://doi.org/10.1046/j.1523-1755.1999.07101.x
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.Journal of Clinical Investigation, 1998
- Intermediate-Density Lipoprotein Is a DNA Synthesis Stimulation Factor in Cultured Human Mesangial CellsNephron, 1996
- Effect of lovastatin on the development of polycystic kidney disease in the han:SPRD ratAmerican Journal of Kidney Diseases, 1995
- Human mesangial cell production of monocyte chemoattractant protein-1: Modulation by lovastatinKidney International, 1995
- Effects of flwastatin on growth of porcine and human vascular smooth muscle cells in vitroThe American Journal of Cardiology, 1995
- Inhibition of human vascular smooth muscle cell proliferation by lovastatin: the role of isoprenoid intermediates of cholesterol synthesisEuropean Journal of Clinical Investigation, 1994
- Effect of Chronic Cholesterol Loading in the Development of Acute Ischemic Renal Failure in RatsRenal Failure, 1994
- Lovastatin but not enalapril reduces glomerular injury in Dahl salt-sensitive rats.Hypertension, 1992
- Inhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733)Atherosclerosis, 1992
- ras isoprenylation is required for ras-induced but not for NGF-induced neuronal differentiation of PC12 cells.The Journal of cell biology, 1991